definiens: means all Patents Controlled by [COMPANY] or its Affiliates on the Effective Date or at any time during the TermCovering ( i ) the composition of matter of a Product, or ( ii ) methods of using a Product as a prophylactic or therapeutic ; provided, however, Patents Controlled by [COMPANY] or any of its Affiliates that include only claims that are directed to ( y ) subject matter applicable to oligonucleotidecompounds or Products in general or ( z ) an oligonucleotide compound that does not specifically modulate expression of DNM2 via thebinding, partially or wholly, of such compound to RNA that encodes DNM2, will not be considered [COMPANY] Product - Specific Patents, and in thecase of ( y ) and ( z ), such Patents will be considered [COMPANY] Core Technology Patents . A representative list of [COMPANY] Product - Specific Patents asof the Effective Date is set forth on Appendix 5